Bright Minds Biosciences (Bright Minds Biosciences) Scaled Net Operating Assets : -0.03 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Bright Minds Biosciences Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Bright Minds Biosciences's operating assets for the quarter that ended in Mar. 2024 was $0.44 Mil. Bright Minds Biosciences's operating liabilities for the quarter that ended in Mar. 2024 was $0.60 Mil. Bright Minds Biosciences's Total Assets for the quarter that ended in Dec. 2023 was $5.13 Mil. Therefore, Bright Minds Biosciences's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was -0.03.

Bright Minds Biosciences Scaled Net Operating Assets Historical Data

The historical data trend for Bright Minds Biosciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bright Minds Biosciences Scaled Net Operating Assets Chart

Bright Minds Biosciences Annual Data

Trend

Sep20

Sep21

Sep22

Sep23

Scaled Net Operating Assets

-0.08

-0.43

-0.05

-0.01

Bright Minds Biosciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial													-0.05	-0.03	-0.01	-0.10	-0.03

Competitive Comparison of Bright Minds Biosciences's Scaled Net Operating Assets

For the Biotechnology subindustry, Bright Minds Biosciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bright Minds Biosciences's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bright Minds Biosciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Bright Minds Biosciences's Scaled Net Operating Assets falls into.

Bright Minds Biosciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Bright Minds Biosciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Sep. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Sep. 2023 )
=	(Operating Assets (A: Sep. 2023 )	-	Operating Liabilities (A: Sep. 2023 ))	/	Total Assets (A: Sep. 2022 )
=	(0.097	-	0.153)	/	9.061
=	-0.01

where

	Operating Assets		(A: Sep. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	5.084	-	4.987
=	0.097

	Operating Liabilities		(A: Sep. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.208	-	0	-	0.055
=	0.153

Bright Minds Biosciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(0.443	-	0.599)	/	5.133
=	-0.03

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	4.825	-	4.382
=	0.443

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.625	-	0	-	0.026
=	0.599

Bright Minds Biosciences Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Bright Minds Biosciences's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Bright Minds Biosciences (Bright Minds Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bright Minds Biosciences Inc (NAS:DRUG) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

DRUG:Canada

Address

19 Vestry Street, New York, NY, USA, 10013

Website

https://www.brightmindsbio.com

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.